The new bisphosphonate ibandronate in the treatment of tumor-induced hypercalcemia

Onkologie

Volumn 22, Issue 3, 1999, Pages 208-211

  Herrmann, Z ^a   Schoter K H ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Bisphosphonates; Ibandronate; Tumor osteolysis; Tumor induced hypercalcemia

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID;

BREAST TUMOR; CALCIUM BLOOD LEVEL; CANCER RECURRENCE; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; OSTEOLYSIS; RELAPSE; RETROSPECTIVE STUDY; SHORT SURVEY;

EID: 0345189473     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026952     Document Type: Short Survey

References (7)

1. Wüster C, Schöter KH, Thiébaud D, Manegold C, Krahl D, Clemens MR, Ghielmini M, Jaeger P, Sharla SH: Methylpentylaminopropylidenebisphosphonate (BM 21.0955): A new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia. Bone Mineral 1993;22:77-85.
2. Pecherstorfer M, Herrmann Z, Body JJ, Manegold C, Degardin M, Clemens MR, Thürlimann B, Tubiana-Hulin M, Steinhauer EU, van Eijkeren M, Huss HJ, Thiébaud D: Randomized phase-II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. J Clin Oncol 1996;14:268-276.
3. Ralston SH, Thiébaud D, Herrmann Z, Steinhauer EU, Thürlimann B, Walls J, Lichinitser MR, Rizzoli R, Hagberg H, Huss HJ, Tubiana-Hulin M, Body JJ: Dose response study of ibandronate in treatment of cancer-associated hypercalcaemia. Br J Cancer 1997; 75:295-300.
4. ®, pamidronate disodium for injection. Medical Economics 48th Edition 1994, pp 813-815.
5. Nussbaum SR, Younger J, VandePol CJ, Gagel RF, Zubler MA; Chapman R, Henderson IC, Mallette LE: Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg cosages. Am J Med 1993;95:297-304.
6. Gucalp R, Ritch P, Wiernik PH, Sarma PR, Keller A, Richman SP, Tauer K, Neidhart J, Mallette LE, Siegel R, VandePol CJ: Comparative study of pamidronate sodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 1992;10: 134-142.
7. Bauss F: Ibandronate in malignant bone diseases and osteoporosis - preclinical results. Onkologie 1997;20: 204-208.